Similarly, studies on lymphoma and prostate cancer demonstrated that MYC promotes the expression of mitochondrial glutaminase through the direct repression of miR-23a and miR-23b, that, in turn, inhibit mitochondrial glutaminase expression. This evidence concerns the gene MYC and prostate cancer.